nach oben

Erschienen in:

2019 | OriginalPaper | Buchkapitel

51. Verhaltenstherapie und psychopharmakologische Behandlung

verfasst von : Prof. em. Dr. Dr. H.-C. Steinhausen

Erschienen in: Lehrbuch der Verhaltenstherapie, Band 3

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Verhaltenstherapie und Psychopharmakatherapie sind aufgrund ihrer Evidenzbasierung und Praktikabilität zentrale und unverzichtbare Bestandteile der klinischen Versorgung von Kindern und Jugendlichen mit psychischen Störungen und haben daher in allen klinischen Leitlinien einen besonderen Stellenwert. Dieses Kapitel fasst für vier bedeutsame klinische Störungen den aktuellen Wissensstand zur Wirksamkeit und Nützlichkeit dieser Interventionen zusammen: die Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS), Angststörungen, Depression und Zwangsstörungen. Dabei werden jeweils die Erkenntnisse zur Verhaltenstherapie und zur Psychopharmakotherapie getrennt sowie auch die differenziellen Wirkungen der beiden Interventionen dargestellt, bevor zusammenfassende Schlussfolgerungen für die klinische Praxis gezogen werden. Das Kapitel schließt mit einem Ausblick auf wünschenswerte zukünftige Entwicklungen dieser Therapien für Kinder und Jugendliche.

Abikoff, H. (2001). Tailored psychosocial treatments for ADHD: the search for a good fit. Journal of Clinical Child Psychology, 30(1), 122–125.

Arnberg, A., & Ost, L.G. (2014). CBT for children with depressive symptoms: a meta-analysis. Cognitive Behavior Therapy, 43, 255–288.PubMed

Arnold, L. E., Chuang, S., Davies, M. et al. (2004). Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. Journal of Abnormal Child Psychology, 32(1), 39–51.PubMed

Banaschewski, T. Buitelaar, J., Chui, C. S., Coghill, D., Cortese, S. Simonoff, E., Wong, I. C. (2016). Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater. Evidence-based Mental Health 19(4), 97–99.PubMed

Bandelow, B., Heise, C. A., Banaschewski, T., & Rothenberger, A. (2006). Handbuch Psychopharmaka für das Kindes- und Jugendalter. Göttingen: Hogrefe.

Barkley, R. A. (2000). Commentary on the multimodal treatment study of children with ADHD. Journal of Abnormal Child Psychology, 28(6), 595–599.PubMed

Benjamin, C. L., Harrison, J. P., Settipani, C. A., Brodman, D. M., & Kendall, P. C. (2013). Anxiety and related outcomes in young adults 7 to 19 years after receiving treatment for child anxiety. Journal of Consulting and Clinical Psychology, 81(5), 865–876.PubMed

Bloch, M.H., & Storch, E. A. (2015). Assessment and management of treatment-refractory obsessive-compulsive disorder in children. Journal of the Amerian Academy of Child and Adolescent Psychiatry, 54(4), 251–262.

Cheung, A. H., Emslie, G. J., & Mayes, T. L. (2005). Review of the efficacy and safety of antidepressants in youth depression. Journal of Child Psychology and Psychiatry, 46(7), 735–754.PubMed

Compton, S. N., Almirall, D., Birmaher, B., Sherrill, J., Kendall, P. C., March, J. S., Gosch, E. A., Ginsburg, G. S., Rynn, M. A., Piacentini, J. C., McCracken, J. T., Keeton, C. P., Suveg, C. M., Aschenbrand, S. G., Sakolsky, D., Iyengar, S., Walkup, J. T., & Albano, A. M. (2014). Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial. Journal of Consulting and Clinical Psychology, 82(2), 212–224.

Cortese, S., Adamo, N., Mohr-Jensen, C., Hayes, A. J., Bhatti, S., Carucci, S., Del Giovane, C., Atkinson, L. Z., Banaschewski, T., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H. C., Shokraneh, F., Xia, J., Cipriani, A., Coghill, D. (2017). European ADHD Guidelines Group (EAGG). Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis. BMJ Open 7(1): e013967.PubMedPubMedCentral

Cortese, S., Ferrin, M., Brandeis, D., Buitelaar, J., Daley, D., Dittmann, R. W., Holtmann, M., Santosh, P., Stevenson, J., Stringaris, A., Zuddas, A., Sonuga-Barke, E. J., & European ADHD Guidelines Group (2015). Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of the American Academy of Child and Adolescent Psychiatry, 54, 164–174.

Cox, G. R., Callahan, P., Churchill, R., Hunot, V., Merry, S. N., Parker, A. G., & Hetrick, S. E. (2014). Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Systematic Reviews, 11: CD008324.

Daley, D., van der Oord, S., Ferrin, M., Danckaerts, M., Doepfner, M., Cortese, S., Sonuga-Barke, E. J., & European ADHD Guidelines Group (2014). Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. Journal of the American Academy of Child and Adolescent Psychiatry, 53, 835–847.

Döpfner, M., Breuer, D., Schürmann, S., Wolff Metternich, T., & Lehmkuhl, G. (2004). Effectiveness of an adaptive multimodal treatment in children with attention-deficit hyperactivity disorder – global outcome. European Child and Adolescent Psychiatry, 13 (Suppl. 1), I/117–I/129.

Döpfner, M., Ise, E., Wolff Metternich-Katzman, T., Schürmann, S., Rademacher, C., & Breuer, D. (2015). Adaptive Multimodal Treatment for Children with Attention-Deficit-/Hyperactivity Disorder: An 18 Month Follow-Up. Child Psychiatry and Human Development, 46, 44–56.

Faraone, S. V. (2009). Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths. Pharmacy and Therapeutics, 34(12), 678–694.

Franklin, M., Foa, E., & March, J. S. (2003). The Pediatric Obessive-Compulsive Disorder Treatment Study: Rationale, design, and methods. Journal of Child and Adolescent Psychopharmacology, 13 (Suppl. 1), S39–S51.

Franklin, M. E., Sapyta, J., Freeman, J. B., Khanna, M., Compton, S., Almirall, D., Moore, P., Choate-Summers, M., Garcia, A., Edson, A. L., Foa, E. B., & March, J. S., (2011). Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA, 306, 1224–1232.PubMedPubMedCentral

Franklin, M. E., Kratz, H. E., Freeman, J. B., Ivarsson, T., Heyman, I., Sookman, D., McKay, D., Storch, E. A., March, J., & Accreditation Task Force of The Canadian Institute for Obsessive Compulsive Disorders (2015). Cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: Empirical review and clinical recommendations. Psychiatry Research, 227(1), 78–92.PubMed

Freeman, J., Garcia, A., Frank, H., Benito, K., Conelea, C., Walther, M., & Edmunds J (2014a). Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder. Journal of Clinical Child and Adolescent Psychology, 43, 7–26.

Freeman, J., Sapyta, J., Garcia, A., Compton, S., Khanna, M., Flessner, C., FitzGerald, D., Mauro, C., Dingfelder, R., Benito, K., Harrison, J., Curry, J., Foa, E., March, J., Moore, P., & Franklin, M. (2014b). Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr) - a randomized clinical trial. JAMA Psychiatry, 71, 689–698.PubMedPubMedCentral

Garcia, A. M., Sapyta, J. J., Moore, P.S., Freeman, J. B., Franklin, M. E., March, J. S., & Foa, E. B. (2010). Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). Journal of the American Academy of Child and Adolescent Psychiatry, 49, 1024–1033.

Gerlach, M., Mehler-Wex, C., Walitza, S., Warnke, A., & Wewetzer, C. (2009). Neuro-Psychopharmaka im Kindes- und Jugendalter. Grundlagen und Therapie. Wien, New York: Springer.

Greene, R. W., & Ablon, J. S. (2001). What does the MTA study tell us about effective psychosocial treatment for ADHD? Journal of Clinical Child Psychology, 30(1), 114–121.

Harwood, T. M., & Beutler, L. E. (2001). Commentary on Greene and Ablon: What does the MTA study tell us about effective psychosocial treatment for ADHD? Journal of Clinical Child Psychology, 30(1), 141–143.

Hazell, P., & Mirzaie, M. (2013). Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev. 18, 6:CD002317.

Hirshfeld-Becker, D.R., Masek, B., Henin, A., Blakely, L. R., Pollok-Wurman, R. A., McQuade, J., DePetrillo, L., Briesch, J., Ollendick, T. H., Rosenbaum, J. F., & Biederman, J. (2010). Cognitive-behavioral therapy for 4–7 year old children with anxiety disorders: a randomized clinical trial. Journal of Consulting and Clinical Psychology, 78, 498–510.PubMed

Hoza, B. (2001). Psychosocial treatment issues in the MTA: a reply to Greene and Ablon. Journal of Clinical Child Psychology, 30(1), 126–130.

In-Albon, T., & Schneider, S. (2007). Psychotherapy of childhood anxiety disorders: A meta-analysis. Psychotherapy and Psychosomatics, 76(1), 15–24.

Ivarsson, T., Skarphedinsson, G., Kornør, H., Axelsdottir, B., Biedilæ, S., Heyman, I., Asbahr, F., Thomsen, P. H., Fineberg, N., March, J., & Accreditation Task Force of The Canadian Institute for Obsessive Compulsive Disorders (2015). The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis. Psychiatry Research, 227(1), 93–103.PubMed

James, A. C., James, G., Cowdrey, F. A., Soler, A., & Choke, A. (2015). Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Systematic Reviews,18, 2:CD004690.

Jensen, P. S., Hinshaw, S. P., Kraemer, H. C., et al. (2001). ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 147–158.

Jensen, P. S., Arnold, L. E., Swanson, J. M., et al. (2007). 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 989–1002.

March, J. S., Swanson, J. M., Arnold, L. E., et al. (2000). Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). Journal of the Abnormal Child Psychology, 28(6), 527–541.

McCarty, C. A., & Weisz, J. R. (2007). Effects of psychotherapy for depression in children and adolescents: what we can (and can’t) learn from meta-analysis and component profiling. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7), 879–886.

McGuire, J.F., Piacentini, J., Lewin, A. B., Brennan, E. A., Murphy, T. K., & Storch, E. A. (2015). A meta-analysis for cognitive behaviour therapy and medication for child obsessive-compulsive disorders: modertors of treatment efficacy, response and remission. Depression & Anxiety, 32, 580–593.PubMedPubMedCentral

Michael, K. D., & Crowley, S. L. (2002). How effective are treatments for child and adolescent depression? A meta-analytic review. Clinical Psychology Review, 22(2), 247–269.PubMed

Molina, B. S., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., Elliott, G. R., Greenhill, L. L., Newcorn, J. H., Wells, K. C., Wigal, T., Gibbons, R. D., Hur, K., Houck, P. R., & MTA Cooperative Group (2009). The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48(5), 484–500.

MTA Cooperative Group (1999a). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Archives of General Psychiatry, 56(12), 1073–1086.

MTA Cooperative Group. (1999b). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56(12), 1088–1096.

MTA Cooperative Group. (2004). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics, 113(4), 754–761.

Ollendick, T. H., & Seligman, L. D. (2005). Anxiety disorders. In C. Gillberg, R. Harrington, & H.-C. Steinhausen (Hrsg.), A Clinician’s Handbook of Child and Adolescent Psychiatry. Cambridge: Cambridge University Press.

Pelham, W. E. Jr. (1999). The NIMH multimodal treatment study for attention-deficit hyperactivity disorder: Just say yes to drugs alone? Canadian Journal of Psychiatry, 44(10), 981–990.PubMed

Pelham, W. E., Gnagy, E. M., Greiner, A. R., et al. (2000). Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology, 28(6), 507–525.

Piacentini, J., Bennett, S., Compton, S. N., Kendall, P. C., Birmaher, B., Albano, A. M., March, J., Sherrill, J., Sakolsky, D., Ginsburg, G., Rynn, M., Bergman, R. L., Gosch, E., Waslick, B., Iyengar, S., McCracken, J., Walkup, J. (2014). 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). Journal of the American Academy of Child and Adolescent Psychiatry, 53(3), 297–310.

Pössel, P., & Hautzinger, M. (2006). Effekte pharmakologischer und psychotherapeutischer Interventionen auf Depressionen bei Kindern und Jugendlichen. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 34, 243–255.PubMed

POTS Team (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. Jama, 292, 1969–1976.Rapoport, J. L., & Inoff-Germain, G. (2000). Practitioner review: treatment of obsessive-compulsive disorder in children and adolescents. Journal of Child Psychology and Psychiatry, 41, 419–431.

Prasad, V., Brogan, E., Mulvaney, C., Grainge, M., Stanton, W., & Sayal, K. (2013). How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. European Child and Adolescent Psychiatry, 22, 203–216.

Reynolds, S., Wilson, C., Austin, J., & Hooper, L. (2012). Effects of psychotherapy for anxiety in children and adolescents: A meta-analytic review. Clinical Psychology Review, 32, 251–262.PubMed

Rothenberger, A., & Steinhausen, H.-C. (2005). Medikamente für die Kinderseele. Göttingen: Hogrefe.

Schneider, S. (2004). Angststörungen bei Kindern und Jugendlichen. Berlin: Springer.

Schneider, S., & Döpfner, M. (2004). Leitlinien zur Diagnostik und Psychotherapie von Angst- und phobischen Störungen im Kindes- und Jugendalter: Ein evidenzbasierter Diskussionsvorschlag. Kindheit und Entwicklung, 13, 80–96.

Schneider, S., Blatter-Meunier, J., Herren, C., Adornetto, C., In-Albon, T., & Lavallee, K. (2011). Disorder-specific cognitive-behavioral therapy for separation anxiety disorder in young children: a randomized waiting-list-controlled trial. Psychotherapy and Psychosomatics, 80(4), 206–215.PubMed

Schwartz, S., & Correll, C. U. (2014). Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression. Journal of the American Academy of Child and Adolescent Psychiatry, 53(2), 174–187.

Skarphedinsson, G., Weidle, B., Thomsen, P. H., Dahl, K., Torp, N. C., Nissen, J. B., Melin, K. H., Hybel, K., Valderhaug, R., Wentzel-Larsen, T., Compton, S. N., & Ivarsson, T. (2015). Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial. European Child and Adolescent Psychiatry, 24, 591–602.

Steinhausen, H.-C. (2009). Klinischer Verlauf. In H.-C. Steinhausen, A. Rothenberger, & M. Döpfner (Hrsg.), Handbuch Aufmerksamkeits-Defizit-Hyperaktivitätsstörung (ADHS). Stuttgart: Kohlhammer.

Storebø, O.J., Krogh, H. B., Ramstad, E., Moreira-Maia, C. R., Holmskov, M., Skoog, M., Nilausen, T. D., Magnusson, F. L., Zwi, M., Gillies, D., Rosendal, S., Groth, C., Rasmussen, K. B., Gauci, D., Kirubakaran, R., Forsbøl, B., Simonsen, E., & Gluud, C. (2015). Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.British Medical Journal, 351, h5203.

Swanson, J. M., Kraemer, H. C., Hinshaw, S. P., et al. (2001). Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 168–179.

Swanson, J. M., Arnold, L. E., Vitiello, B., et al. (2002). Response to commentary on the multimodal treatment study of ADHD (MTA): Mining the meaning of the MTA. Journal of Abnormal Child Psychology, 30(4), 327–332.PubMed

Taylor, E. (1999). Development of clinical services for attention-deficit/hyperactivity disorder. Archives General Psychiatry, 56(12), 1097–1099.PubMed

Thulin, U., Svirsky, L., Serlachius, E., Andersson, G., & Ost, L. G. (2014). The effect of parent involvement in the treatment of anxiety disorders in children: a meta-analysis. Cognitive Behavior Therapy, 43(3), 185–200.PubMed

Torp, N. C., Dahl, K., Skarphedinsson, G., Compton, S., Thomsen, P. H., Weidle, B., Hybel, K., Valderhaug, R., Melin, K., Nissen, J. B., & Ivarsson, T. (2015). Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 54, 200–207.

Walkup. J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., Iyengar, S., March, J. S., & Kendall, P. C. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766.

Waters, A. M., Ford, L. A., Wharton, T. A., & Cobham, V. E. (2009). Cognitive-behavioural therapy for young children with anxiety disorders: Comparison of a child + parent condition versus a parent only condition. Behaviour Research and Therapy, 47, 654–662.PubMed

Weisz, J. R., McCarty, C. A., & Valeri, S. M. (2006). Effects of psychotherapy for depression in children and adolescents: A meta-analysis. Psychological Bulletin, 132(1), 132–149.PubMedPubMedCentral

Wells, K. C. (2001). Comprehensive versus matched psychosocial treatment in the MTA study: Conceptual and empirical issues. Journal of Clinical Child Psychology, 30(1), 131–135.

Wells, K. C., Pelham, W. E., Kotkin, R. A., et al. (2000). Psychosocial treatment strategies in the MTA study: Rationale, methods, and critical issues in design and implementation. Journal of the Abnormal Child Psychology, 28(6), 483–505.

Whalen, C. K. (2001). ADHD treatment in the 21st century: Pushing the envelope. Journal of Clinical Child Psychology, 30(1), 136–140.

Zhou, X., Hetrick, S. E., Cuijpers, P., Qin, B., Barth, J., Whittington, C. J., Cohen, D., Del Giovane, C., Liu, Y., Michael, K. D., Zhang, Y., Weisz, J. R. & Xie, P. (2015). Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis. World Psychiatry, 14, 2017–2222.PubMedPubMedCentral

Bandelow, B., Heise, C. A., Banaschewski, T., & Rothenberger, A. (2006). Handbuch Psychopharmaka für das Kindes- und Jugendalter. Göttingen: Hogrefe.

Gerlach, M., Mehler-Wex, C., Walitza, S., Warnke, A., & Wewetzer, C. (2009). Neuro-Psychopharmaka im Kindes- und Jugendalter. Grundlagen und Therapie. (2. Aufl.). Wien, New York: Springer.

Steinhausen, H.-C. (2016). Psychische Störungen bei Kindern und Jugendlichen (8. Aufl.). München: Elsevier, Urban & Fischer.

Titel: Verhaltenstherapie und psychopharmakologische Behandlung
verfasst von: Prof. em. Dr. Dr. H.-C. Steinhausen
Verlag: Springer Berlin Heidelberg
Buch: Lehrbuch der Verhaltenstherapie, Band 3
Print ISBN: 978-3-662-57368-6

Electronic ISBN: 978-3-662-57369-3

Copyright-Jahr: 2019
DOI: https://doi.org/10.1007/978-3-662-57369-3_51

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

51. Verhaltenstherapie und psychopharmakologische Behandlung

Zusammenfassung

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko